Drug
Sutacimig
Sutacimig: highest development phase Phase 3, developed by Hemab ApS. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Hemab ApS
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sutacimig NCT07935356 | Phase 3 | Thrombasthenia |
Latest
No recent events.
Follow Sutacimig on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.